| Translated title of the contribution | Phase II cohort study in patients with metastatic castration-resistant prostate cancer (mCRPC) with new cohorts: Phase Ib/II study on combination therapies with pembrolizumab (MK-3475) in patients with mCRPC (KEYNOTE-365) - AP 94/16 Study of the AUO |
|---|---|
| Original language | German |
| Pages (from-to) | 504-505 |
| Number of pages | 2 |
| Journal | Aktuelle Urologie |
| Volume | 53 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Dec 2022 |
| Externally published | Yes |
Phase-II-Kohortenstudie bei Patienten mit metastasiertem kastrationsresistentem Prostatakarzinom (mCRPC) mit neuen Kohorten: Phase-Ib/II-Studie zu Kombinationstherapien mit Pembrolizumab (MK-3475) bei Patienten mit mCRPC (KEYNOTE- 365) – Studie AP 94/ 16 der AUO
Heidrun Rexer, Margitta Retz, Peter Hammerer
Research output: Contribution to journal › Comment/debate